capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine]
- RxCUI
- 1422563
- RxNorm name
- capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine]
- Display name
- MEDI-DERM WITH LIDOCAINE (Topical)
- Full name
- capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine]
- Term type
- SBD
- Status
- Active
- Strength
- 0.035-2-5-20%
- Dose form
- Cream
- Route
- Topical
- Updated
- 2026-07-30 22:39:12
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062013
- Active start
- 062013
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| capsaicin | 0.35 MG / 1 ML | capsaicin | capsaicin |
| methyl salicylate | 200 MG / 1 ML | methyl salicylate | methyl salicylate |
| lidocaine | 20 MG / 1 ML | lidocaine | lidocaine |
| menthol | 50 MG / 1 ML | menthol | menthol |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Cream | 316982 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| capsaicin | 1992 |
| methyl salicylate | 29787 |
| lidocaine | 6387 |
| menthol | 6750 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream | 1 | NAMES |
| RxNorm Name | capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine] | 1 | NAMES |
| RxNorm Synonym | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| RxCUI | 1422563 | 1 | CODES |
UNII Substances#
No records found.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a1eced33-f9ee-4757-ab94-75f238f9b2a9 | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream [PSN] · capsaicin 0.35 MG/ML / lidocaine 20 MG/ML / menthol 50 MG/ML / methyl salicylate 200 MG/ML Topical Cream [Medi-Derm with Lidocaine] [SBD] · Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream [SY] | 3 | 5 | 20190206 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 89decf1f-d69c-40f2-80e1-cbdb6e1601a7 | Two Hip Consulting, LLC | 20190206 | |
| a1eced33-f9ee-4757-ab94-75f238f9b2a9 | Two Hip Consulting, LLC | 20190206 | |
| 1842fcb9-06f8-4359-a478-e6953bdbd2da | National Council for Prescription Drug Programs | 20130303 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | lidocaine | |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | lidocaine | |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | lidocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | lidocaine | |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | lidocaine | |
| ATC | M02AB | Capsaicin and similar agents | ATC1-4 | capsaicin | |
| ATC | C05AD | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | S01HA | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | N01BX | Other local anesthetics | ATC1-4 | capsaicin | |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D002211 | Capsaicin | CHEM | has_ingredient | capsaicin |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D008610 | Menthol | CHEM | has_ingredient | menthol |
| MEDRT | D012459 | Salicylates | CHEM | has_ingredient | methyl salicylate |
| MEDRT | D059787 | Acute Pain | DISEASE | may_treat | methyl salicylate |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D001168 | Arthritis | DISEASE | may_treat | methyl salicylate |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | methyl salicylate |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D003288 | Contusions | DISEASE | may_treat | methyl salicylate |
| MEDRT | D003929 | Diabetic Neuropathies | DISEASE | may_treat | capsaicin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | capsaicin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | menthol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methyl salicylate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D006562 | Herpes Zoster | DISEASE | may_treat | capsaicin |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methyl salicylate |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009120 | Muscle Cramp | DISEASE | may_treat | methyl salicylate |
| MEDRT | D009437 | Neuralgia | DISEASE | may_treat | capsaicin |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | menthol |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | capsaicin |
| MEDRT | D012871 | Skin Diseases | DISEASE | may_treat | menthol |
| MEDRT | D013180 | Sprains and Strains | DISEASE | may_treat | methyl salicylate |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | menthol |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | methyl salicylate |
| MEDRT | N0000000105 | Neurotransmitter Transporter Interactions | MOA | has_moa | capsaicin |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | methyl salicylate |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | methyl salicylate |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | capsaicin |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | menthol |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | methyl salicylate |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.35 MG/ML / 20 MG/ML / 50 MG/ML / 200 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | Medi-Derm with Lidocaine (capsaicin 0.035 % / lidocaine 2 % / menthol 5 % / methyl salicylate 20 % ) Topical Cream |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Micromedex RED BOOK |